Clay Thorp
Director, Clearside Biomedical, Inc.
Companies
- Clearside Biomedical, Inc.Board member Jun 1, 2016 to Feb 24, 20251
- PhaseBio Pharmaceuticals IncBoard member Oct 17, 2018 to May 19, 20232
- Vigil Neuroscience, Inc.Board member Jan 6, 2022 to May 17, 20223
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- PhaseBio Pharmaceuticals Inc3,581,733 shares4May 19, 2023
- Clearside Biomedical, Inc.3,721,181 shares5Feb 24, 2025
- Vigil Neuroscience, Inc.1,559,030 shares6May 17, 2022
As of each latest filing. The line shows shares held over time.
Recent filings
- Feb 24, 2025Bought 15,000 shares at $0.92 of Clearside Biomedical, Inc.5
- Sep 25, 2023Bought 10,000 shares at $0.86 of Clearside Biomedical, Inc.7
- May 19, 2023Exercised options 3,750 shares of PhaseBio Pharmaceuticals Inc4
- Dec 21, 2022Bought 14,000 shares at $1.02 of Clearside Biomedical, Inc.8
- Dec 15, 2022Other 8,522 shares of Clearside Biomedical, Inc.9
- Dec 15, 2022Other 1,406,507 shares of Clearside Biomedical, Inc.9
- May 17, 2022Bought 14,893 shares at $2.97 of Vigil Neuroscience, Inc.6
- May 16, 2022Bought 21,802 shares at $2.76 of Vigil Neuroscience, Inc.6
- Mar 28, 2022Bought 3,000 shares at $7.20 of Vigil Neuroscience, Inc.10
- Jan 11, 2022Bought 265,000 shares at $14.00 of Vigil Neuroscience, Inc.11
- Jan 11, 2022Converted 1,254,335 shares of Vigil Neuroscience, Inc.11
- Feb 10, 2021Sold 32,873 shares at $4.43 of Clearside Biomedical, Inc.12
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7SEC EDGARForm 4 filed Sep 25, 2023
- 8SEC EDGARForm 4 filed Dec 21, 2022
- 9SEC EDGARForm 4 filed Dec 19, 2022
- 10SEC EDGARForm 4 filed Mar 28, 2022
- 11SEC EDGARForm 4 filed Jan 11, 2022
- 12SEC EDGARForm 4 filed Dec 19, 2022